Hadassah Medical Organization
Jerusalem, Israel
NCT Number: NCT01753258
The focus of this pilot study is to determine if a woman who experiences pain during sexual intercourse has a higher risk of complications during labor and delivery secondary to pelvic floor dysfunction, anxiety and intolerance towards pelvic examinations. Furthermore, it is unclear whether women with prepartum dyspareunia experience an improvement following vaginal delivery. While physicians may expect that vaginal birth improves dyspareunia due to the stretching effect on pelvic floor, to date, there is insufficient evidence to support this claim. The Investigators plan to prospectively study 200 patients at our Institution, collect information regarding birth and follow them, via questionnaires, regarding their dyspareunia postpartum.
Looking for future studies?
Notify Me18 year–50 year
Female
Observational
Jerusalem, Israel
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 months -1 year
The Investigators will record the mode of delivery (vaginal, instrumental or cesarean section), length of the second stage of labor, use of anesthetics, perineal tears and\\or episiotomies, and newborn's birth weight. The evaluation will be done prospectively, comparing data with matched controls without a history of dyspareunia.
Time frame: 2 years
Hadassah Medical Organization
Other
Outcomes of Delivery in Patients With Dyspareunia- A Prospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03199534
Dyspareunia, Female Urogenital Diseases
Kirkland, Washington, United States
View Trial DetailsNCT06660212
Dyspareunia, Female Urogenital Diseases
Ottawa, Ontario, Canada
View Trial DetailsNCT05417334
Dyspareunia, Female Urogenital Diseases
Barcelona, Spain
View Trial DetailsNCT03216330
Central Sensitisation, Dyspareunia
Vancouver, British Columbia, Canada
View Trial Details